PON2
Basic information
Region (hg38): 7:95404862-95435329
Links
Phenotypes
GenCC
Source:
- amyotrophic lateral sclerosis (Supportive), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (68 variants)
- not_provided (8 variants)
- PON2-related_disorder (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PON2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000305.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 15 | ||||
missense | 43 | 51 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 46 | 18 | 5 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PON2 | protein_coding | protein_coding | ENST00000222572 | 9 | 30336 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000544 | 0.891 | 125428 | 2 | 318 | 125748 | 0.00127 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.755 | 154 | 183 | 0.843 | 0.00000893 | 2306 |
Missense in Polyphen | 31 | 36.806 | 0.84225 | 465 | ||
Synonymous | -0.343 | 73 | 69.4 | 1.05 | 0.00000342 | 697 |
Loss of Function | 1.49 | 9 | 15.3 | 0.589 | 7.09e-7 | 207 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00170 | 0.00170 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000647 | 0.000647 |
European (Non-Finnish) | 0.00195 | 0.00194 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000819 | 0.000817 |
Other | 0.00147 | 0.00147 |
dbNSFP
Source:
- Function
- FUNCTION: Capable of hydrolyzing lactones and a number of aromatic carboxylic acid esters. Has antioxidant activity. Is not associated with high density lipoprotein. Prevents LDL lipid peroxidation, reverses the oxidation of mildly oxidized LDL, and inhibits the ability of MM-LDL to induce monocyte chemotaxis. {ECO:0000269|PubMed:11579088, ECO:0000269|PubMed:15772423}.;
- Pathway
- Phase I biotransformations, non P450;Metabolism of lipids;Synthesis of 5-eicosatetraenoic acids;Arachidonic acid metabolism;Metabolism;Fatty acid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.516
Intolerance Scores
- loftool
- 0.823
- rvis_EVS
- 0.4
- rvis_percentile_EVS
- 76.15
Haploinsufficiency Scores
- pHI
- 0.132
- hipred
- N
- hipred_score
- 0.248
- ghis
- 0.462
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.996
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Pon2
- Phenotype
- immune system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- response to oxidative stress;response to toxic substance;lipoxygenase pathway;aromatic compound catabolic process
- Cellular component
- extracellular region;nucleus;mitochondrion;lysosome;plasma membrane
- Molecular function
- arylesterase activity;identical protein binding;metal ion binding;acyl-L-homoserine-lactone lactonohydrolase activity